Specialty Counseling & Consulting - Medicare Mental Health Clinic in Cheyenne, WY

Specialty Counseling & Consulting is a medicare enrolled mental health clinic (Community/behavioral Health) in Cheyenne, Wyoming. The current practice location for Specialty Counseling & Consulting is 4025 Rawlins St, Cheyenne, Wyoming. For appointments, you can reach them via phone at (307) 426-4798. The mailing address for Specialty Counseling & Consulting is 4025 Rawlins St, Cheyenne, Wyoming and phone number is (307) 426-4798.

Specialty Counseling & Consulting is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1538462783. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (307) 426-4798.

Contact Information

Specialty Counseling & Consulting
4025 Rawlins St
Cheyenne
WY 82001-1900
(307) 426-4798
(307) 426-4798

Mental Health Clinic Profile

Full NameSpecialty Counseling & Consulting
SpecialityCommunity/Behavioral Health
Location4025 Rawlins St, Cheyenne, Wyoming
Authorized Official Name and PositionRobert Logan (OWNER/OPERATOR)
Authorized Official Contact3074264798
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Specialty Counseling & Consulting
4025 Rawlins St
Cheyenne
WY 82001-1900

Ph: (307) 426-4798
Specialty Counseling & Consulting
4025 Rawlins St
Cheyenne
WY 82001-1900

Ph: (307) 426-4798

NPI Details:

NPI Number1538462783
Provider Enumeration Date12/09/2010
Last Update Date10/27/2023
Certification Date10/27/2023

Medicare PECOS Information:

Medicare PECOS PAC ID8921311911
Medicare Enrollment IDO20150720002981

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Specialty Counseling & Consulting such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1538462783NPI-NPPES
130259100MedicaidWY
9000142271MedicaidCO

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103T00000XPsychologist PHD-419 (Wyoming)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry 15431 (Colorado)Secondary
251S00000XCommunity/behavioral Health (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Specialty Counseling & Consulting acts as a billing entity for following providers:
Provider NameDenise Mcclellan
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1851732549
PECOS PAC ID: 1557593233
Enrollment ID: I20190725003180

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameRaul A Padilla
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1932481124
PECOS PAC ID: 6608043518
Enrollment ID: I20191001001863

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameTara Monique Rios Vega
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1710406319
PECOS PAC ID: 3971938879
Enrollment ID: I20200211001538

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameSandra J Brausch
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1932282837
PECOS PAC ID: 4385056399
Enrollment ID: I20201216001761

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameRandi Losalu
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1598243156
PECOS PAC ID: 3072920628
Enrollment ID: I20210325002095

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameAmy Mavy
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1942490792
PECOS PAC ID: 8820405921
Enrollment ID: I20210407000663

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameMegan Bowman
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1427460237
PECOS PAC ID: 2769870112
Enrollment ID: I20211104001188

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameBrooke Jostad
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1578939864
PECOS PAC ID: 2264764521
Enrollment ID: I20220429000512

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameRachel Taylor
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1326703489
PECOS PAC ID: 1456705433
Enrollment ID: I20230925002009

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameClay William Dokken
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1154626711
PECOS PAC ID: 7214385996
Enrollment ID: I20231120001666

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameDaniel A Bort
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1114148020
PECOS PAC ID: 6800244500
Enrollment ID: I20231120002557

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameRandall Alan Basden
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1831311760
PECOS PAC ID: 3375991714
Enrollment ID: I20231127001120

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameTracey Harris
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1639843345
PECOS PAC ID: 7315396157
Enrollment ID: I20231206000233

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameJonna Langston
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1750635678
PECOS PAC ID: 5092163907
Enrollment ID: I20240103003961

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameBeatriz Carolina Grullon
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1811403371
PECOS PAC ID: 6709234206
Enrollment ID: I20240104003969

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameKalyn K Krotz
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1316106503
PECOS PAC ID: 3173974813
Enrollment ID: I20240108003567

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameGary R King
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1346405016
PECOS PAC ID: 0446601199
Enrollment ID: I20240108003912

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameEric Z Williams
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1043816960
PECOS PAC ID: 2961853445
Enrollment ID: I20240109002892

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameRobert A Logan
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1134342199
PECOS PAC ID: 3375856362
Enrollment ID: I20240110003716

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

Provider NameDawn Marie Marchak
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1578836805
PECOS PAC ID: 6800244302
Enrollment ID: I20240110005250

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more Medical News

› Verified 9 days ago

News Archive

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

New 'super food' breakthrough in sports nutrition

RESEARCHERS have found that antioxidant-rich watercress, often labelled a super-food, can alleviate the natural stress put on our body by a workout.

Early palliative care treatment for lung cancer can help patients live longer: Research

Introducing palliative care at an early stage of treatment for advanced lung cancer could help patients to live for longer, as well as improving their mood and quality of life.

Congress focuses on cognitive treatment for troops with traumatic brain injuries

A bipartisan group of 74 lawmakers issued a letter Friday demanding that the Pentagon's health plan cover a treatment for brain-injured soldiers known as cognitive rehabilitation therapy.

Dehaier Medical fourth quarter revenues increase 126% to $6.7 million

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial results for the fourth quarter and 12 months ended December 31, 2010.

Read more News

› Verified 9 days ago

Community/Behavioral Health in Cheyenne, WY

Mindfully Reconnect Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1001 W 31st St, Cheyenne, WY 82001
Phone: 307-634-6883    Fax: 307-634-9462
Rescare Wyoming, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 6215 Clear Creek Pkwy, Cheyenne, WY 82007
Phone: 307-432-9824    
Kw Therapy, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1910 Pioneer Ave, Cheyenne, WY 82001
Phone: 970-315-2375    Fax: 844-965-9818
2.0 Counseling Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2321 Dunn Ave, Cheyenne, WY 82001
Phone: 307-316-2757    Fax: 307-316-8811
Gloria D Rutt Psyd Pc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2305 Coulter Drive, Cheyenne, WY 82009
Phone: 307-286-4106    Fax: 307-632-6588
Speak Life Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1816 E 17th St, Cheyenne, WY 82001
Phone: 307-426-4204    
Cheyenne Child And Family Counseling Center, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 721 E Lincolnway, Cheyenne, WY 82001
Phone: 307-631-9213    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.